Stock CRVS CORVUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Corvus Pharmaceuticals, Inc.

Equities

CRVS

US2210151005

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
1.45 USD -2.03% Intraday chart for Corvus Pharmaceuticals, Inc. +3.57% -17.61%
04-09 Corvus Pharmaceuticals, Inc. Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis CI
03-20 Oppenheimer Trims Corvus Pharmaceuticals Price Target to $7 From $8, Maintains Outperform Rating MT

Chart calendar Corvus Pharmaceuticals, Inc.

838f7bcd30be71ee6066b62cd8dc.Wx4b6zE4_Dj2eL2aq8cZTsRcbFxZa6DrxSKfwiCDBOE.L39tmAhCpkygG__M4otXF_RuPzpsOM-xmlDRoFbBbrA8eGmhVgm3dqQN1g~1fcd1427eeaaf14236cfdc5cccc2068f

Upcoming events on Corvus Pharmaceuticals, Inc.

07/05/2024 Q1 2024 Earnings Release (Projected)
13/06/2024 21:00 Annual General Meeting
31/07/2024 Q2 2024 Earnings Release (Projected)
30/10/2024 Q3 2024 Earnings Release (Projected)
05/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Corvus Pharmaceuticals, Inc.

19/03/2024 20:30 Q4 2023 Earnings Call
19/03/2024 20:02 Q4 2023 Earnings Release
07/02/2024 Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases
12/12/2023 02:00 American Society of Hematology Meeting - Abstract No 4278
10/12/2023 01:30 American Society of Hematology Meeting - Abstract No 1442
07/11/2023 21:30 Q3 2023 Earnings Call
07/11/2023 21:01 Q3 2023 Earnings Release
07/09/2023 13:30 CPI-818 Phase 3 Clinical Trial Results Call
08/08/2023 21:30 Q2 2023 Earnings Call
08/08/2023 21:01 Q2 2023 Earnings Release
28/06/2023 Japanese Cancer Association and American Association for Cancer Research Precision Cancer Medicine I
15/06/2023 21:00 Annual General Meeting
15/06/2023 11:30 International Malignant Lymphoma Meeting - Abstract #: 193
07/06/2023 14:30 Jefferies Global Healthcare Conference
08/05/2023 21:30 Q1 2023 Earnings Call
08/05/2023 21:01 Q1 2023 Earnings Release
17/04/2023 14:00 American Association for Cancer Research Meeting - Abstract No 1813
28/03/2023 Whistler Global Summit
28/03/2023 21:30 Q4 2022 Earnings Call
28/03/2023 21:05 Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-48,9
-50,0
2.2%		-43,8
-43,7
-0.12%		-38,6
-40,8
5.21%		-32,6
-36,9
11.78%		-23,4
-23,6
0.78%
-33,1

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-46,7
-46,9
0.52%		-6,00
-56,9
89.47%		-43,2
-42,9
-0.82%		-41,3
-42,3
2.36%		-27,0
-26,5
-1.89%
-32,9

Net income
Million USD		Released
Forecast
Spread 		-46,7
-46,9
0.52%		-6,00
-41,0
85.37%		-43,2
-42,9
-0.82%		-41,3
-42,3
2.36%		-27,0
-26,5
-1.82%
-33,1

EPS
USD		Released
Forecast
Spread 		-1,59
-1,57
-1.6%		-0,20
-1,39
85.61%		-1,03
-0,98
-4.75%		-0,89
-0,91
2.2%		-0,56
-0,55
-1.82%
-0,57

Announcement Date05/03/2025/03/2110/03/2228/03/2319/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-6,81
-8,94
23.84%		-7,41
-7,49
1.03%		-7,01
-8,11
13.49%		-12,5
-6,96
-79.1%		-5,67
-10,0
43.41%		-6,57
-6,23
-5.56%		-5,62
-5,97
5.75%		-5,56
-6,09
8.64%		-5,65
-5,83
3.11%
-6,41


-7,09


-8,28


-9,08

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,24
-8,86
-4.29%		-8,30
-7,54
-10.04%		-8,36
-8,09
-3.42%		-14,8
-7,35
-101.77%		-9,82
-10,8
9.19%		-7,87
-7,42
-6.04%		-6,50
-6,48
-0.3%		-6,00
-5,53
-8.55%		-6,65
-6,15
-8.18%
-7,36


-7,34


-8,58


-9,65

Net income
Million USD		Released
Forecast
Spread 		-9,24
-8,86
-4.29%		-8,30
-7,54
-10.04%		-8,36
-8,22
-1.74%		-14,8
-7,35
-101.77%		-9,82
-10,8
9.19%		-7,87
-7,42
-6.04%		-6,50
-6,48
-0.3%		-6,00
-5,98
-0.38%		-6,65
-6,17
-7.89%
-6,56


-7,03


-8,16


-9,01

EPS
USD		Released
Forecast
Spread 		-0,20
-0,19
-7.14%		-0,18
-0,15
-17.39%		-0,18
-0,18
-1.88%		-0,32
-0,16
-104.25%		-0,21
-0,23
8.7%		-0,17
-0,16
-8.51%		-0,14
-0,14
0%		-0,12
-0,12
2.04%		-0,14
-0,13
-10.52%
-0,13


-0,13


-0,15


-0,16

Announcement Date10/03/2205/05/2208/08/2203/11/2228/03/2308/05/2308/08/2307/11/2319/03/24----

Upcoming sector events for Corvus Pharmaceuticals, Inc.

28/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
28/04/2024 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
28/04/2024 MORPHOSYS AG: Q1 2024 Earnings Release
29/04/2024 21:05 QIAGEN N.V.: Q1 2024 Earnings Release
29/04/2024 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
30/04/2024 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Corvus Pharmaceuticals, Inc.

Today GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
Today GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 06:00 BB BIOTECH AG: Q1 2024 Earnings Release
25/04/2024 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
25/04/2024 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
25/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 12:00 MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
25/04/2024 07:00 PURETECH HEALTH PLC: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CRVS Stock
  4. Calendar Corvus Pharmaceuticals, Inc.